SynthesisHaematologica2015

Efficacy of rituximab maintenance therapy for aggressive B-cell lymphoma depends on use of rituximab in induction therapy: a meta-analysis of randomized controlled trials.

Yasuhito Nannya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.